Loading provider…
Loading provider…
Nephrology Physician in Lafayette, IN
NPI: 1447228184Primary Practice Location
INDIANA UNIVERSITY HEALTH ARNETT HOSPITAL
5165 McCarty Ln, Lafayette, IN
Primary Employer
Arnett Clinic, LLC
iuhealth.org
HQ Phone
Get MD Akram's Phone Numberphone_androidMobile
Get MD Akram's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
IN State Medical License
1997 - 2025
MI State Medical License
1995 - 1999

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
Detroit Medical Center/Wayne State University
Fellowship • Nephrology
1996 - 1998
MedStar Health Georgetown University/Harbor Hospital
Residency • Internal Medicine
1993 - 1996
Damascus University Faculty of Medicine
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 230 | 305 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 150 | 187 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 61 | 119 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 58 | 127 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 53 | 61 |
Authors: Koubar, Sahar H, Hatab, Taha, Razzak, Farah Abdul, Helal, Imed, Ali, Ala, Shebani, Abdulhafid, Kaysi, Saleh, Gunderman, David, Al-Makki, Akram, Davison, Sara N
Journal: Kidney Int Rep
Publication Date: 2025-01-16
Lead Sponsor: Merit Medical Systems, Inc.
Intervention / Treatment: DEVICE: CentrosFLO Long Term Hemodialysis Catheter
Lead Sponsor: Affymax
Collaborators: Takeda
Intervention / Treatment: DRUG: Darbepoetin alfa, DRUG: peginesatide
Lead Sponsor: Ash Access Technology
Intervention / Treatment: DRUG: Heparin, DEVICE: AAT-023 solution (Zuragen)